FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096283909> ?p ?o ?g. }

• W2096283909 endingPage "2755" @default.
• W2096283909 startingPage "2748" @default.
• W2096283909 abstract "ABSTRACT Endogenous antimicrobial peptides of the cathelicidin family contribute to innate immunity. The emergence of widespread antibiotic resistance in many commonly encountered bacteria requires the search for new bactericidal agents with therapeutic potential. Solid-phase synthesis was employed to prepare linear antimicrobial peptides found in cathelicidins of five mammals: human (FALL39/LL37), rabbit (CAP18), mouse (mCRAMP), rat (rCRAMP), and sheep (SMAP29 and SMAP34). These peptides were tested at ionic strengths of 25 and 175 mM against Pseudomonas aeruginosa , Escherichia coli , Staphylococcus aureus , and methicillin-resistant Staphylococcus aureus . Each peptide manifested activity against P. aeruginosa irrespective of the NaCl concentration. CAP18 and SMAP29 were the most effective peptides of the group against all test organisms under both low- and high-salt conditions. Select peptides of 15 to 21 residues, modeled on CAP18 (37 residues), retained activity against the gram-negative bacteria and methicillin-sensitive S. aureus , although the bactericidal activity was reduced compared to that of the parent peptide. In accordance with the behavior of the parent molecule, the truncated peptides adopted an α-helical structure in the presence of trifluoroethanol or lipopolysaccharide. The relationship between the bactericidal activity and several physiochemical properties of the cathelicidins was examined. The activities of the full-length peptides correlated positively with a predicted gradient of hydrophobicity along the peptide backbone and with net positive charge; they correlated inversely with relative abundance of anionic residues. The salt-resistant, antimicrobial properties of CAP18 and SMAP29 suggest that these peptides or congeneric structures have potential for the treatment of bacterial infections in normal and immunocompromised persons and individuals with cystic fibrosis." @default.
• W2096283909 created "2016-06-24" @default.
• W2096283909 creator A5018411482 @default.
• W2096283909 creator A5037321572 @default.
• W2096283909 creator A5050473740 @default.
• W2096283909 creator A5055976158 @default.
• W2096283909 creator A5058479824 @default.
• W2096283909 creator A5058806039 @default.
• W2096283909 creator A5066272764 @default.
• W2096283909 creator A5069373690 @default.
• W2096283909 creator A5084243657 @default.
• W2096283909 creator A5085725734 @default.
• W2096283909 date "2000-05-01" @default.
• W2096283909 modified "2023-10-18" @default.
• W2096283909 title "Bactericidal Activity of Mammalian Cathelicidin-Derived Peptides" @default.
• W2096283909 cites W1960714279 @default.
• W2096283909 cites W1971642218 @default.
• W2096283909 cites W1973592863 @default.
• W2096283909 cites W1976301815 @default.
• W2096283909 cites W1981854518 @default.
• W2096283909 cites W2002066211 @default.
• W2096283909 cites W2003318145 @default.
• W2096283909 cites W2007807255 @default.
• W2096283909 cites W2010980975 @default.
• W2096283909 cites W2027585104 @default.
• W2096283909 cites W2027998177 @default.
• W2096283909 cites W2030642888 @default.
• W2096283909 cites W2032994693 @default.
• W2096283909 cites W2034280103 @default.
• W2096283909 cites W2036090704 @default.
• W2096283909 cites W2036917159 @default.
• W2096283909 cites W2038471033 @default.
• W2096283909 cites W2038717313 @default.
• W2096283909 cites W2039983391 @default.
• W2096283909 cites W2044373024 @default.
• W2096283909 cites W2050242176 @default.
• W2096283909 cites W2051142131 @default.
• W2096283909 cites W2051158595 @default.
• W2096283909 cites W2053353201 @default.
• W2096283909 cites W2057809675 @default.
• W2096283909 cites W2058223359 @default.
• W2096283909 cites W2063259818 @default.
• W2096283909 cites W2063951978 @default.
• W2096283909 cites W2066432956 @default.
• W2096283909 cites W2097098774 @default.
• W2096283909 cites W2100266303 @default.
• W2096283909 cites W2128112850 @default.
• W2096283909 cites W2132998789 @default.
• W2096283909 cites W2136538608 @default.
• W2096283909 cites W2140313585 @default.
• W2096283909 cites W2144599944 @default.
• W2096283909 cites W2145517314 @default.
• W2096283909 cites W2167705901 @default.
• W2096283909 cites W2178996695 @default.
• W2096283909 cites W2286897117 @default.
• W2096283909 cites W4211190410 @default.
• W2096283909 doi "https://doi.org/10.1128/iai.68.5.2748-2755.2000" @default.
• W2096283909 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/97484" @default.
• W2096283909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10768969" @default.
• W2096283909 hasPublicationYear "2000" @default.
• W2096283909 type Work @default.
• W2096283909 sameAs 2096283909 @default.
• W2096283909 citedByCount "338" @default.
• W2096283909 countsByYear W20962839092012 @default.
• W2096283909 countsByYear W20962839092013 @default.
• W2096283909 countsByYear W20962839092014 @default.
• W2096283909 countsByYear W20962839092015 @default.
• W2096283909 countsByYear W20962839092016 @default.
• W2096283909 countsByYear W20962839092017 @default.
• W2096283909 countsByYear W20962839092018 @default.
• W2096283909 countsByYear W20962839092019 @default.
• W2096283909 countsByYear W20962839092020 @default.
• W2096283909 countsByYear W20962839092021 @default.
• W2096283909 countsByYear W20962839092022 @default.
• W2096283909 countsByYear W20962839092023 @default.
• W2096283909 crossrefType "journal-article" @default.
• W2096283909 hasAuthorship W2096283909A5018411482 @default.
• W2096283909 hasAuthorship W2096283909A5037321572 @default.
• W2096283909 hasAuthorship W2096283909A5050473740 @default.
• W2096283909 hasAuthorship W2096283909A5055976158 @default.
• W2096283909 hasAuthorship W2096283909A5058479824 @default.
• W2096283909 hasAuthorship W2096283909A5058806039 @default.
• W2096283909 hasAuthorship W2096283909A5066272764 @default.
• W2096283909 hasAuthorship W2096283909A5069373690 @default.
• W2096283909 hasAuthorship W2096283909A5084243657 @default.
• W2096283909 hasAuthorship W2096283909A5085725734 @default.
• W2096283909 hasBestOaLocation W20962839092 @default.
• W2096283909 hasConcept C104317684 @default.
• W2096283909 hasConcept C136449434 @default.
• W2096283909 hasConcept C170493617 @default.
• W2096283909 hasConcept C2776634448 @default.
• W2096283909 hasConcept C2777379352 @default.
• W2096283909 hasConcept C2777637488 @default.
• W2096283909 hasConcept C2779281246 @default.
• W2096283909 hasConcept C2779489039 @default.
• W2096283909 hasConcept C2780183148 @default.
• W2096283909 hasConcept C4937899 @default.
• W2096283909 hasConcept C523546767 @default.

• next